LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

Search

Kala Pharmaceuticals Inc

Gesloten

0.94 -1.05

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

0.84

Max

0.99

Belangrijke statistieken

By Trading Economics

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+64.84% upside

Kala Pharmaceuticals Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

28 nov 2025, 15:29 UTC

Belangrijke Marktbewegers
Acquisities, Fusies, Overnames

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

28 nov 2025, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

28 nov 2025, 19:59 UTC

Marktinformatie

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

28 nov 2025, 19:47 UTC

Marktinformatie

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

28 nov 2025, 18:16 UTC

Marktinformatie

Global Equities Roundup: Market Talk

28 nov 2025, 18:16 UTC

Marktinformatie

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov 2025, 18:08 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

28 nov 2025, 18:08 UTC

Marktinformatie

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov 2025, 17:48 UTC

Marktinformatie

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

28 nov 2025, 17:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

28 nov 2025, 16:50 UTC

Acquisities, Fusies, Overnames

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

28 nov 2025, 15:51 UTC

Marktinformatie

Canada Household Spending Edges Lower -- Market Talk

28 nov 2025, 15:33 UTC

Marktinformatie

Crude Futures Gain as U.S. Market Reopens -- Market Talk

28 nov 2025, 15:21 UTC

Marktinformatie

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

28 nov 2025, 15:13 UTC

Marktinformatie

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

28 nov 2025, 15:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

28 nov 2025, 15:11 UTC

Marktinformatie

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

28 nov 2025, 14:51 UTC

Marktinformatie

Canada GDP Report Masks Fragile State of Economy -- Market Talk

28 nov 2025, 14:41 UTC

Marktinformatie

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

28 nov 2025, 14:37 UTC

Marktinformatie

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

28 nov 2025, 14:33 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

28 nov 2025, 14:33 UTC

Marktinformatie

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

28 nov 2025, 14:20 UTC

Marktinformatie

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

28 nov 2025, 14:10 UTC

Marktinformatie

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

28 nov 2025, 13:39 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

28 nov 2025, 13:39 UTC

Marktinformatie

Canada Trade Data Could Face Larger-Than-Normal Revisions -- Market Talk

28 nov 2025, 13:36 UTC

Marktinformatie

Canada's Economy Expands More Than Expected -- Market Talk

28 nov 2025, 13:29 UTC

Marktinformatie

CME Outage Sowing Chaos Across Markets, Trade Nations Says -- Market Talk

28 nov 2025, 13:27 UTC

Marktinformatie

Russia-Ukraine Peace Efforts to Have Little Impact on Oil Fundamentals -- Market Talk

28 nov 2025, 13:19 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Kala Pharmaceuticals Inc Prognose

Koersdoel

By TipRanks

64.84% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 1.5 USD  64.84%

Hoogste 1.5 USD

Laagste 1.5 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Kala Pharmaceuticals Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

2 ratings

0

Buy

2

Hold

0

Sell

Financieel

$

Over Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat